您的当前位置:首页正文

USE OF CDK9 AND BRD4 INHIBITORS TO INHIBIT INFLAMM

2020-01-25 来源:步旅网
专利内容由知识产权出版社提供

专利名称:USE OF CDK9 AND BRD4 INHIBITORS TO

INHIBIT INFLAMMATION

发明人:HAUDENSCHILD, Dominik,YIK, Jasper申请号:EP15850918.2申请日:20151013公开号:EP3206749A4公开日:20180620

摘要:Provided are methods for the combined use of cyclin-dependent kinase 9(CDK9) inhibitors and bromodomain containing 4 (BRD4) inhibitors to reduce, inhibitand/or prevent cartilage degradation and systemic traumatic inflammation. A

combination of CDK9 inhibitors and BRD4 inhibitors can be used to reduce, inhibit and/orprevent cartilage degradation and loss of cartilage viability during allograft storage. Acombination of CDK9 inhibitors and BRD4 inhibitors can be used as a post-injuryintervention treatment to reduce, inhibit and/or prevent the acute cellular responsesthat lead to future cartilage degradation and osteoarthritis.

申请人:The Regents of the University of California

地址:1111 Franklin Street, 12th Floor Oakland, CA 94607-5200 US

国籍:US

代理机构:Patent Boutique LLP

更多信息请下载全文后查看

因篇幅问题不能全部显示,请点此查看更多更全内容